StimLabs is a company based in the United States that operates within the retail sector, specifically focusing on vitamins, supplements, and health products. Founded in 2015, the company has developed expertise in the application of dehydrated human placental membrane (dCHPM) allografts for various medical procedures, particularly in wound care and reconstruction. Their published documents primarily consist of case studies that detail the use of fenestrated dCHPM in complex surgical repairs, such as those following Mohs micrographic surgery for skin cancer and traumatic injuries. These case studies illustrate the integration and effectiveness of dCHPM in promoting wound healing and tissue regeneration, highlighting its application in both aesthetic and functional restoration of affected areas. The company’s documentation reflects a commitment to advancing medical practices through innovative tissue engineering solutions, emphasizing the importance of optimal wound bed conditions and the biological properties of placental membranes in clinical outcomes. StimLabs employs between 201 and 500 individuals and has reported revenue figures indicative of its operational scale.